Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis

• Main Authors: Xueqiong Xun (Author), Jun Ai (Author), Fuhui Feng (Author), Pan Hong (Author), Saroj Rai (Author), Ruikang Liu (Author), Baowen Zhang (Author), Yeming Zhou (Author), Huiyong Hu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Triple-negative breast cancer (TNBC) and HER-2 negative metastatic breast cancer (HER-2 negative MBC) are intractable to various treatment schemes. Bevacizumab as a novel anti-VEGF drug, its safety for these two high-risk breast cancers remains controversial. Therefore, we conducted this...